How much do know about diabetes long acting solution liraglutide intermediates?

As a medical raw material for the treatment of diabetes, diabetes long-acting solution liraglutide intermediates are very unique. Different from other drugs for the treatment of diabetes, diabetes long-acting solution liraglutide intermediates have very small side effects. While lowering the blood sugar of the patient, will not cause the trouble of hypoglycemia. Therefore, it is welcomed by patients and doctors. At present, diabetes long-acting solution The market for liraglutide intermediates is in short supply.

What is the current market situation of liraglutide?

Why does liraglutide receive strong attention?

Is liraglutide different from other diabetes medications?

What is the current market situation of liraglutide?

Diabetes, as a difficult disease, has become an important public health problem. People need to prevent and treat diabetes.

However, hypoglycemic drugs emerge one after another in the market. Most hypoglycemic drugs have side effects and risks of hypoglycemia. As a new hypoglycemic drug, liraglutide has its unique mechanism and low risk of hypoglycemia, but more evidence-based medical evidence is still needed for the safety and effectiveness of the long-term application.

In addition, adiponectin, as a protective factor of the body, improving the level of adiponectin is more beneficial to people's health. If liraglutide can improve the level of human serum adiponectin, it will have a broader prospect. However, the relationship between them and the specific mechanism needs to be further studied.

Why does liraglutide receive strong attention?

liraglutide is an analog of human glucagon-like peptide 1. It has a unique mechanism of action and can improve pancreatic islets β Cell function, promote islet β It is a new hypoglycemic drug with broad application prospects. Adiponectin is a highly specific adipokine expressed in adipocytes and has a protective effect on the human body. It can improve insulin resistance, anti-atherosclerosis and inhibit inflammation. It is of great significance to detect the level of adiponectin in serum. Studies on mice at home and abroad have found that liraglutide may improve insulin sensitivity by up-regulating the level of adiponectin.

Is liraglutide different from other diabetes medications?

At present, there are several major categories of mainstream products for the treatment of diabetes in the world: One is insulin. Insulin is the only hormone in the body that lowers blood sugar. It has obvious short-term effects after injection, but it will cause the human body to "depend on" in the long term. It can only treat the symptoms rather than the root cause. ; The second is oral hypoglycemic drugs represented by DPP4 inhibitors. The main mechanism is to decompose protein in the body, stimulate insulin, inhibit glucagon, and regenerate islet cells to reduce blood sugar. The disadvantage is that it can only be moderate. Lowering blood sugar cannot effectively control the risk of complications; the third type is liraglutide. This type of treatment not only has multiple hypoglycemic mechanisms but also liraglutide can improve insulin sensitivity and effectively improve insulin resistance. The therapeutic effect of treating both symptoms and root causes. liraglutide stimulates the proliferation and differentiation of pancreatic β-cells and promotes the secretion of somatostatin, thereby significantly reducing the risk of major cardiovascular events in patients with type 2 diabetes (T2DM), and greatly reducing the health and health effects of complications for patients with diabetes. Death threats.

Under the current circumstances, liraglutide will inevitably be welcomed by the market. Chengdu Pukang Company is a professional company that produces liraglutide. Here, you can order high-quality liraglutide. For more information, please contact them.